Results 131 to 140 of about 12,357,672 (189)

Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways. [PDF]

Pharmaceuticals (Basel)
Gao M, Liu F, Feng X, Wang M, Zhang Z, Li H, Wang C, Sun J.   +7 more
europepmc   +1 more source

Schisandrin B Alleviates Renal Tubular Cell Epithelial-Mesenchymal Transition and Mitochondrial Dysfunction by Kielin/Chordin-like Protein Upregulation via Akt Pathway Inactivation and Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase Pathway Activation in Diabetic Kidney Disease. [PDF]

Molecules, 2023
Liu W, Li F, Guo D, Du C, Zhao S, Li J, Yan Z, Hao J.   +7 more
europepmc   +1 more source

Schisandrin B alleviates metabolic associated fatty liver disease by regulating the PPARγ signaling pathway and gut microbiota in mice. [PDF]

Front Pharmacol
Wan J, Lang C, Gao M, Liu F, Feng X, Li H, Wang C, Sun J.   +7 more
europepmc   +1 more source

Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis. [PDF]

Front Pharmacol, 2022
Fang Y, Zhang L, Wang Z, Wang R, Liang S.   +4 more
europepmc   +1 more source

Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth. [PDF]

Front Pharmacol
Jiang B, Yang J, Huang Q, Li W, Peng Q, Gan H, Peng T, Yao L, Qi L.   +8 more
europepmc   +1 more source

Study on the Role of Schisandrin B in Ameliorating Hepatic Ischemia-Reperfusion Injury by Modulating Hepatocyte Autophagy. [PDF]

Iran J Pharm Res
Fei Z, Haihang P, Xueyang C, Miao S.
europepmc   +1 more source

Schisandrin B regulates the SIRT1/PI3K/Akt signaling pathway to ameliorate Ang II-infused cardiac fibrosis. [PDF]

Iran J Basic Med Sci
Zhang X, Shi M, Xing Z, Su J, Gu Y, Ning Z.   +5 more
europepmc   +1 more source

Schisandrin B Inhibits LPS-Induced Endometritis Through Attenuating Ferroptosis via AMPK/PGC1α/Nrf2 Signalling Pathway. [PDF]

J Cell Mol Med
Yu J, Li X, Zhou M, Lu M, Ruan Z, Zou W, Yu S.   +6 more
europepmc   +1 more source

Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest. [PDF]

Sci Rep
Fang Y, Lv X, Li G, Wang P, Zhang L, Wang R, Jia L, Liang S.   +7 more
europepmc   +1 more source

In vivo and in vitro investigations of schisandrin B against angiotensin II induced ferroptosis and atrial fibrosis by regulation of the SIRT1 pathway. [PDF]

Sci Rep
Shi M, Ning Z.
europepmc   +1 more source